WallStreetZenWallStreetZen

NASDAQ: MDXG
Mimedx Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MDXG

Based on 2 analysts offering 12 month price targets for Mimedx Group Inc.
Min Forecast
$11.00+41.94%
Avg Forecast
$11.50+48.39%
Max Forecast
$12.00+54.84%

Should I buy or sell MDXG stock?

Based on 2 analysts offering ratings for Mimedx Group Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MDXG stock forecasts and price targets.

MDXG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Mizuho
Top 50%
51
Strong BuyMaintains$12.00+54.84%2023-08-02Find out why
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$11.00+41.94%2023-08-02

1 of 1

Forecast return on equity

Is MDXG forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.73%

Forecast return on assets

Is MDXG forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.11%

MDXG revenue growth forecast

How is MDXG forecast to perform vs Biotechnology companies and vs the US market?
Company
11.8%
Industry
34.63%
Market
8.12%
MDXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDXG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MDXG$7.75$11.50+48.39%Strong Buy
ARDX$4.14$8.63+108.33%Strong Buy
IMTX$11.22$12.00+6.95%Strong Buy
NAMS$9.10$22.00+141.76%Buy
PRME$9.54$20.25+112.26%Strong Buy
View Top Biotech Stocks

Mimedx Group Stock Forecast FAQ

Is Mimedx Group Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MDXG) stock is to Strong Buy MDXG stock.

Out of 2 analysts, 1 (50%) are recommending MDXG as a Strong Buy, 1 (50%) are recommending MDXG as a Buy, 0 (0%) are recommending MDXG as a Hold, 0 (0%) are recommending MDXG as a Sell, and 0 (0%) are recommending MDXG as a Strong Sell.

If you're new to stock investing, here's how to buy Mimedx Group stock.

What is MDXG's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: MDXG) forecast ROE is N/A, which is considered weak.

What is MDXG's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MDXG price target, the average MDXG price target is $11.50, with the highest MDXG stock price forecast at $12.00 and the lowest MDXG stock price forecast at $11.00.

On average, Wall Street analysts predict that Mimedx Group's share price could reach $11.50 by Aug 2, 2024. The average Mimedx Group stock price prediction forecasts a potential upside of 48.39% from the current MDXG share price of $7.75.

What is MDXG's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: MDXG) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.